Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Beverley M. Shields, Catherine D. Angwin, Maggie H. Shepherd, Nicky Britten, Angus G. Jones, Naveed Sattar, Rury Holman, Ewan R. Pearson, Andrew T. Hattersley (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)
27 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds